当前位置: 首页 > 期刊 > 《中医药临床杂志》 > 2011年第21期 > 正文
编号:12153062
格列齐特缓释片对老年初诊2型糖尿病病人的疗效观察(2)
http://www.100md.com 2011年11月1日 王蜀鄂
第1页

    参见附件(2064KB,2页)。

     综上所述,对于新发的老年糖尿病患者,以达美康缓释片作为起始的每日一次治疗方案,可以作为一种优化治疗方案。

    参考文献

    [1]American Diabetes Association.Clinical Practice Recommendations 2006.Diabetes Care.2006;29:$43-$48.

    [2]安雅莉,等.中华内分泌代谢杂志,2008;24(3):256-260

    [3]Festa A,Williams K,D’Agostino R,eta1.The natural course of β-cell function in nondiabetic and diabetic individuals.The Insulin Resistance Atherosclerosis study.Diabetes.2006;55:1114-1120.

    [4]中华医学会内分泌学会.中华内分泌代谢杂志。2011;27(5):371-374

    [5]Zimmet P,Alberti KG,Shaw J.Global and societal implications of the diabelesepidemic.Nature.2001;414:782-787.

    [6]Wei M,Gaskill SP,Haffner SM,Stern ME Effects of diabetes and level ofglycemia on a11-cause and cardiovascular mortality,The San Anlonio Heart Study.Diabetes Care.1998;21:1167-1172.

    [7]Morrish NJ,Wang SL,Stevens LK,Fuller JH.Keen H.Mortality and causes of death in lhe WHO Multinational Study of Vascular Disease in Diabetes.Diabetologia.2001;44(suppl 2):S14-S21.

    [8]The Diabetes Control and Complications Trial Research Group.The effect of ntensive treatment of diabetes on the development and progression 0f long’term complications in insulin dependent diabetes mellitus.N Eng J Med.1993;329:977-986.

    [9]UK Prospective Diabetes Study(UKPDS)Group.Intensive blood-glucose control with sulphonylureas or insulin compared wiIh conventionaI treatment and risk of complications in patients with type 2 diabetes(UKPDS 33)Lancet.1 998;352:837-853.

    [10]UK Prospective Diabetes Study(UKPDS)Group.Effect of intensive blood-glucose control with metformin on complications in ovenweight patients with type 2 diabetes(UKPDS 34).Lancet.1998;352:854-865.

    [11]Drouin P and the Diamicron MR study group.Diamicron MR is effective and welltolerated once daily in type 2 diabetes:a double.blind.randomized. muItinaliOnaIsludy.J Diabetes Complications.2000;14:185-191.

    作者简介:

    王蜀鄂,女,医学硕士,副主任医师,研究方向:糖尿病及慢性并发症的防治工作

您现在查看是摘要介绍页,详见PDF附件(2064KB,2页)